Bang on!! Let me add some more, don't forget the COVID ARDS trial was not part of the 2020 agenda. It was only GvHD, CHF, and CLBP. How wonderful is that we have now added 300 patients RCT trail will bring hundreds of million $$ into the MSB cash bank. Also, this trial impresses a lot to get Novartis into the board with another billion of $$ partnersship plus a lot will bring future ARDS. So, without whinging on delay we have to thank SI and his team.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-703
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |